FREE Equity Delivery and MF
Flat ₹20/trade Intra-day/F&O
|
Comparision between DelaPlex IPO and Docmode Health Technologies IPO.
DelaPlex IPO is a SME Fixed Price Issue IPO proposed to list at NSE SME while Docmode Health Technologies IPO is a SME Fixed Price Issue proposed to list at NSE SME.
DelaPlex IPO | Docmode Health Technologies IPO | |
---|---|---|
Logo | ||
Issue Category | SME | SME |
Issue Type | IPO | IPO |
Process Type | Book Built Issue | Fixed Price Issue |
Listing At | NSE SME | NSE SME |
Lead Managers | Shreni Shares Limited | Fedex Securities Pvt Ltd |
Registrar | Bigshare Services Pvt Ltd | Bigshare Services Pvt Ltd |
Market Maker | Shreni Shares Limited | Rikhav Securities Limited |
DRHP | DRHP | DRHP |
RHP | RHP | RHP |
Anchor Investor | Anchor Investor | |
IPO Allotment URL | IPO Allotment URL | IPO Allotment URL |
The total issue size of DelaPlex IPO is up to ₹46.08 Cr whereas the issue size of the Docmode Health Technologies IPO is up to ₹6.71 Cr. The final issue price of DelaPlex IPO is ₹192.00 per share and of Docmode Health Technologies IPO is ₹79.00 per share.
DelaPlex IPO | Docmode Health Technologies IPO | |
---|---|---|
Face Value | ₹10 per share | ₹10 per share |
Issue Price (Lower) | ₹186.00 per share | |
Issue Price (Upper) | ₹192.00 per share | |
Issue Price (Final) | ₹192.00 per share | ₹79.00 per share |
Discount (Retail) | ||
Discount (Employee) | ||
Market Lot Size | 600 shares | 1600 shares |
Fresh Issue Size | 18,00,000 shares | 8,49,600 shares |
Fresh Issue Size (Amount) | up to ₹34.56 Cr | up to ₹6.71 Cr |
OFS Issue Size | 6,00,000 shares | |
OFS Issue Size (Amount) | up to ₹11.52 Cr | |
Issue Size Total | 24,00,000 shares | 8,49,600 shares |
Issue Size Total (Amount) | up to ₹46.08 Cr | up to ₹6.71 Cr |
DelaPlex IPO opens on Jan 25, 2024, while Docmode Health Technologies IPO opens on Jan 25, 2024. The closing date of DelaPlex IPO and Docmode Health Technologies IPO is Jan 30, 2024, and Jan 30, 2024, respectively.
DelaPlex IPO | Docmode Health Technologies IPO | |
---|---|---|
Anchor Bid Date | Jan 24, 2024 | |
Issue Open | Jan 25, 2024 | Jan 25, 2024 |
Issue Close | Jan 30, 2024 | Jan 30, 2024 |
Basis Of Allotment (Tentative) | Jan 31, 2024 | Jan 31, 2024 |
Initiation of Refunds (Tentative) | Jan 31, 2024 | Feb 01, 2024 |
Credit of Share (Tentative) | Feb 01, 2024 | Feb 01, 2024 |
Listing date (Tentative) | Feb 02, 2024 | Feb 02, 2024 |
Anchor Lockin End date 1 | Mar 01, 2024 | Mar 01, 2024 |
Anchor Lockin End date 2 | Apr 30, 2024 | Apr 30, 2024 |
DelaPlex IPO P/E ratio is 17.75, as compared to Docmode Health Technologies IPO P/E ratio of 9.3.
DelaPlex IPO | Docmode Health Technologies IPO | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Financial | DelaPlex Limited Financial Information (Restated)DelaPlex Limited's revenue increased by 9.69% and profit after tax (PAT) rose by 29.23% between the financial year ending with March 31, 2023 and March 31, 2022.
|
Docmode Health Technologies Limited Financial Information (Restated Consolidated)Docmode Health Technologies Limited's revenue increased by 165.12% and profit after tax (PAT) rose by 111.3% between the financial year ending with March 31, 2023 and March 31, 2022.
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Promoter Shareholding (Pre-Issue) | 100% | 65.02% | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Promoter Shareholding (Post-Issue) | 73.66% | 47.44% | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
P/E Ratio | 17.75 | 9.3 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Market Cap | ₹174.91 Cr. | ₹24.83 Cr. | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
ROE | 40.45%% | 80.03%% | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
ROCE | 56.73%% | 22.46%% | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Debt/Equity | 2.44 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
EPS | ₹10.82 | ₹8.50 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
RoNW | 56.73%% | 56.06%% |
In the DelaPlex IPO retail investors (RII) are offered 7,97,400 shares while in Docmode Health Technologies IPO retail investors are offered 7,97,400 shares. Qualified institutional buyers (QIB) are offered 4,55,400 shares in DelaPlex IPO and 0 shares in Docmode Health Technologies IPO.
DelaPlex IPO | Docmode Health Technologies IPO | |
---|---|---|
Anchor Investor Reserveration | 6,82,800 shares | |
Market Maker Reserveration | 1,22,400 shares | 43,200 shares |
QIB | 4,55,400 shares | 0 shares |
NII | 3,42,000 shares | 4,03,200 shares |
RII | 7,97,400 shares | 4,03,200 shares |
Employee | 0 shares | 0 shares |
Others | ||
Total | 15,94,800 shares | 8,06,400 shares |
DelaPlex IPO subscribed 177.80x in total, whereas Docmode Health Technologies IPO subscribed 215.24x.
DelaPlex IPO | Docmode Health Technologies IPO | |
---|---|---|
QIB (times) | 90.91x | |
NII (times) | 335.23x | 194.90x |
Big NII (times) | ||
Small NII (times) | ||
RII (times) | 159.91x | 230.38x |
Employee (times) | ||
Other (times) | ||
Total (times) | 177.80x | 215.24x |
Add a public comment...
Rs 0 Account Opening Fee
Free Eq Delivery & MF
Flat ₹20 Per Trade in F&O
FREE Intraday Trading (Eq, F&O)
Flat ₹20 Per Trade in F&O
|